NUCLEOLIN and non-small cell lung carcinoma: Later in 2015, gemcitabine was loaded into the AS1411 aptamer surface-decorated nanopolymersome for selectively targeting the nucleolin-overexpressing NSCLC (non-small-cell lung cancer) cell line, A549 (Alibolandi et al., 2016).